Managing Narcolepsy with XYWAV

Clinical Trials and Research
Written By Kathleen McQuaid

Learn about treatment considerations when managing narcolepsy with XYWAV. XYWAV is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy.

Learn more
Kathleen McQuaid
Previous

STAGES Sleep Study
Next

How much shut-eye do kids really need while learning virtually?